Heather H. Cheng, MD, PhD

/content/dam/www/faculty-photos/C/heather-cheng/heather-cheng.jpg
Dr. Heather Cheng MD, PhD
FACULTY MEMBER

Heather H. Cheng, MD, PhD

Professor, Clinical Research Division, Fred Hutch

Professor
Clinical Research Division, Fred Hutch

Fax: 206.606.2042
Mail Stop: Box 358081

Dr. Heather Cheng focuses on improving the care of patients with prostate and bladder cancers. An expert in prostate cancer genetics, she is studying ways to use genetics to guide the care of prostate cancer patients and their family members who may also be at high risk for the disease. Dr. Cheng leads clinical trials of a variety of new treatments for prostate cancer. She is also developing new tests that could help guide doctors’ choice of treatment for each patient and new blood tests to detect and monitor the progression of prostate cancer.

Other Appointments & Affiliations

Professor, Division of Hematology and Oncology, Department of Medicine, University of Washington

Professor
Division of Hematology and Oncology, Department of Medicine, University of Washington

Education

University of Washington, Hematology/Oncology Fellowship, 2009-2013

University of Washington, Internal Medicine Residency, 2007-2009

University of Washington, School of Medicine, 2007, MD

University of Washington, Program in Molecular and Cellular Biology, 2005, PhD

Research Interests

Tumor and inherited genetics of prostate cancer

Novel therapeutics in prostate cancer

Correlative science/translational studies in clinical trials

Clinical and molecular predictors of response to cancer therapies

Current Projects

A Phase I/II Trial of Concurrent Chemohormonal Therapy Using Enzalutamide (MDV-3100) and

Cabazitaxel in Patients with Metastatic Castration Resistant Prostate Cancer

Monotherapy in Subjects with Metastatic Urothelial Cancer that Express Nectin-4

Clinical Expertise

Prostate Cancer

Prostate Cancer Predisposition and Inherited Cancer Risk 

Cancer Biomarkers 

Clinical Trials and Experimental Therapeutics

Bladder Cancer and Testicular Cancer

Find an Active Clinical Trial Led by Dr. Cheng